Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area epigenetics parp'

Search results for: 'research area epigenetics parp'

Items 1-10 of 70

Page
per page
  1. Veliparib dihydrochloride
    A3958 Veliparib dihydrochloride
    Target: PARP
    Summary: PARP-1/PARP-2 inhibitor
      ≥31.7 mg/mL
  2. AZD2461
    A4164 AZD2461
    Target: PARP
    Summary: Novel PARP inhibitor
      insoluble in H2O; ≥16.35 mg/mL
  3. PJ34
    A3729 PJ34
    Target: PARP
    Summary: PARP-l inhibitor
      ≥50.9 mg/mL
  4. A-966492
    A4160 A-966492
    Target: PARP
    Summary: PARP-1/-2 inhibitor, highly potent
      ≥32.4 mg/mL
  5. UPF 1069
    A4163 UPF 1069
    Target: PARP
    Summary: Selective PARP2 inhibitor
      insoluble in H2O; ≥12.7 mg/mL
  6. Vorinostat (SAHA, MK0683)
    A4084 Vorinostat (SAHA, MK0683)
     9 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor
      insoluble in EtOH; insoluble in H2O; ≥4.41 mg/mL
  7. Mocetinostat (MGCD0103, MG0103)
    A4089 Mocetinostat (MGCD0103, MG0103)
     2 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC inhibitor,isotype-selective and potent
      insoluble in EtOH; insoluble in H2O; ≥19.8 mg/mL
  8. AZD1208
    A3962 AZD1208
    Target: Pim
    Summary: PIM kinase inhibitor
      insoluble in EtOH; insoluble in H2O; ≥18.95 mg/mL
  9. Tubacin
    A4501 Tubacin
     3 Citation
    Target: Histone Deacetylases (HDACs)
    Summary: HDAC6 inhibitor,potent,selective,reversible,cell-permeable
      insoluble in EtOH; insoluble in H2O; ≥7.19 mg/mL
  10. Tenovin-6
    A8302 Tenovin-6
    Target: Sir2-like Family Deacetylases (Sirtuins)
    Summary: SIRT inhibitor and p53 activator
      ≥22.75 mg/mL

Items 1-10 of 70

Page
per page
Shop By
Now Shopping by
  1. Category Signaling Pathways Remove This Item
  2. Reported Experiments Animal Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Apoptosis 2item
  2. Chromatin/Epigenetics 64item
  3. Metabolism 1 item
  4. DNA Damage/DNA Repair 26item
  5. PI3K/Akt/mTOR Signaling 1 item
  6. Cell Cycle/Checkpoint 13item
  7. Ubiquitination/ Proteasome 1 item
  8. JAK/STAT Signaling 9item
  9. Angiogenesis 2item
  10. Stem Cell 2item
  11. Membrane Transporter/Ion Channel 1 item
  12. Neuroscience 2item
Specificity
  1. Selective 48item
Reversibility
  1. Reversible 2item
  2. Irreversible 1 item
Target
  1. Cyclin-Dependent Kinases 1 item
  2. Histone Deacetylases (HDACs) 17item
  3. PI3K 1 item
  4. Aurora Kinases 13item
  5. EZH2 1 item
  6. Bromodomains 3item
  7. FLT3 5item
  8. PLK 1 item
  9. VEGFR 2item
  10. RET 1 item
  11. Bromodomain-containing proteins(BRDs) 1 item
  12. Hydrolase 1 item
  13. DOT1L 1 item
  14. FGFR 1 item
  15. Nrf2 1 item
  16. Pim 1 item
  17. Sir2-like Family Deacetylases (Sirtuins) 4item
  18. PP1 1 item
  19. PP2A 1 item
  20. Src 2item
  21. Trk Receptors 1 item
  22. STAT 1 item
  23. JAK 8item
  24. DNA-PK 1 item
  25. Topoisomerases 1 item
  26. DNA Methyltransferases 2item
  27. Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors (HIF-PHIs) 1 item
  28. CREBBP 1 item
  29. EP300 1 item
  30. LRRK2 1 item
  31. PARP 6item
  32. ALK 1 item
  33. Fatty-acid-binding proteins (FABPs) 1 item
  34. Histamine H1 Receptors 1 item
  35. Hck 1 item
  36. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  37. Cytidine deaminases 1 item
  38. PP4 1 item
  39. c-RET 1 item
  40. VEGFR3/FLT4 1 item
  41. NTRK1/TRKA 1 item
  42. CSF-1R/c-Fms 1 item
  43. PTP 1 item
  44. p53 1 item
  45. Trx 1 item
  46. TYK2 1 item
  47. MUSK 1 item
  48. MAP3K 1 item
  49. p21 1 item
  50. FGR 1 item
  51. YES 1 item
  52. Fyn 1 item
  53. ARG 1 item
  54. TRPC channel 1 item
  55. Sirtuin 1 item
Related Disease
  1. Acute Myeloid Leukemia 7item
  2. Bladder Cancer 2item
  3. Bladder Carcinoma 1 item
  4. Breast Cancer 11item
  5. Cancer 46item
  6. Cervical Cancer 2item
  7. Chronic Lymphocytic Leukemia 1 item
  8. Colon Cancer 6item
  9. Colorectal Cancer 3item
  10. Glioblastoma 1 item
  11. Glioma 2item
  12. Hepatic Cancer 1 item
  13. Hepatocellular Carcinoma 1 item
  14. HIV 1 item
  15. HIV Infections 1 item
  16. Inflammatory Diseases 2item
  17. Leukemia 3item
  18. Lung Cancer 4item
  19. Lymphoma 1 item
  20. Melanoma 1 item
  21. Mixed Lineage Leukemia 1 item
  22. Multiple Myeloma 3item
  23. Myelofibrosis 1 item
  24. Myeloma 1 item
  25. Neuroblastoma 1 item
  26. Neuronal Protection 1 item
  27. Non-small Cell Lung Cancer 1 item
  28. Ovarian Cancer 4item
  29. Pancreatic Cancer 2item
  30. Prostate Cancer 9item
  31. Psoriasis 1 item
  32. Renal Cancer 1 item
  33. Renal Cell Carcinoma 2item
  34. Rheumatoid Arthritis 2item
  35. Thyroid Cancer 1 item
  36. Type 2 Diabetes 3item